(Q45770364)

15 December 2017

title

Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin (English)

1 reference

15 December 2017

0 references

Shyam S Bansal

1

1 reference

15 December 2017

Manicka V Vadhanam

series ordinal

2

1 reference

15 December 2017

Ramesh C Gupta

series ordinal

3

1 reference

15 December 2017

publication date

11 February 2011

1 reference

15 December 2017

published in

Pharmaceutical Research

1 reference

15 December 2017

volume

28

1 reference

15 December 2017

page(s)

1121-1130

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Apoptosis and nuclear factor-kappa B: a tale of association and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Role of polyanhydrides as localized drug carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Injectable biodegradable polyurethane scaffolds with release of platelet-derived growth factor for tissue repair and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Localized paclitaxel delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Therapeutic applications of implantable drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Measurement of protein using bicinchoninic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

In vitro release of trypanocidal drugs from biodegradable implants based on poly(epsilon-caprolactone) and poly(D,L-lactide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Polymer implants for intratumoral drug delivery and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Modeling and comparison of dissolution profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Pharmacokinetics and pharmacodynamics of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Effect of turmeric on xenobiotic metabolising enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0375-Z

Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation

21 January 2018

1 reference

12 December 2020

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

1 reference

12 December 2020

Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats

1 reference

12 December 2020

Mammary tumor induction in ACI rats exposed to low levels of 17beta-estradiol.

1 reference

12 December 2020

Biotransformation of curcumin through reduction and glucuronidation in mice.

1 reference

12 December 2020

Polymeric implants for cancer chemotherapy

1 reference

12 December 2020

The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat

1 reference

12 December 2020

Anticancer potential of curcumin: preclinical and clinical studies.

1 reference

12 December 2020

Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells.

1 reference

12 December 2020

10.1007/S11095-011-0375-Z

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

21311958

1 reference

15 December 2017